MENU
DBVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
DBV Technologies S.A (DBVT) Ownership - Who owns DBV Technologies S.A?
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
177-181 avenue Pierre Brossolette
Phone
+33 155427878
Employees
104
Web
http://www.dbvtechnologies.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
259.34M
P/E Ratio
N/A
Total Cash
103.21M
Projected Growth
N/A
Total Debt
8.29M
Revenue
N/A
Risk (Beta)
-0.90
Dividend Yield
N/A
Total Cash/Share
3.77
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
DBVT
Capitalization
259M
P/E Ratio
N/A
Risk (Beta)
-0.90
Dividend Yield
N/A
Total Cash
103M
Total Cash/Share
3.77
Total Debt
8.29M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
86.2M
P/B Ratio
2.85
Cash Flow
N/A
Earnings
-5.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
15.4M
Current Ratio
2.45
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-115.51M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-95.03
Shares Held By Institutions
16M
Shares Outstanding - Current
27.3M
Total Liabilities
57.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
191.262
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of non invasive epicutaneous diagnostics systems and immunotherapy for allergy diagnostics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
177-181 avenue Pierre Brossolette
Phone
+33 155427878
Employees
104
Web
http://www.dbvtechnologies.com